During the past decade, General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology" are "Multiple Myeloma" (2 trials), "Relapse Multiple Myeloma" (1 trials) and "Renal Impairment" (1 trials). Many other conditions were trialed in "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology" in a lesser frequency.

Most popular intervention types in "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Daratumumab" (1 trials), "Melflufen" (1 trials) and "Melphalan Flufenamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".